Metformin improves the sensitivity of ovarian cancer cells to chemotherapeutic agents.

作者: Chen Yang , Nanan Zhao , Dandan Li , Ge Zou , Yan Chen

DOI: 10.3892/OL.2019.10564

关键词:

摘要: Ovarian cancer is a common tumor of the reproductive system, and primarily responds to cytoreductive surgery cisplatin (DDP)-based chemotherapy. However, chemoresistance results in high ovarian mortality. Therefore, aim present study was investigate effects metformin on apoptosis autophagy drug-resistant SKOV3/DDP cells. To do so, MTT assay, flow cytometry, electron microscopy western blotting were used study. Metformin could inhibit growth SKOV3 cells concentration- time-dependent manner (P<0.05). The half-inhibitory concentration (IC50) values DDP methotrexate (MTX) 14.35 4.21 µg/ml for cells, 70.26 15.27 respectively. In addition, resistance index MTX 4.89 3.62, After combining with MTX, IC50 11.20 2.80 µg/ml, 6.21 2.74 decreased by 11.31- 6.18-fold. This indicated that cell proliferation inhibited when treated combination chemotherapeutic agents, compared agents alone. not observed cells; however, it following incubation 10 mmol/l 48 h. Furthermore, expression levels microtubule-associated protein 1 light chain 3-II upregulated These demonstrated can sensitize may be associated induction autophagy.

参考文章(30)
Agnieszka Sliwinska, Aneta Rogalska, Agnieszka Marczak, Jacek Kasznicki, Jozef Drzewoski, Metformin, but not sitagliptin, enhances WP 631-induced apoptotic HepG2 cell death Toxicology in Vitro. ,vol. 29, pp. 1116- 1123 ,(2015) , 10.1016/J.TIV.2015.04.019
J.A. Jara, R. López-Muñoz, Metformin and cancer: Between the bioenergetic disturbances and the antifolate activity. Pharmacological Research. ,vol. 101, pp. 102- 108 ,(2015) , 10.1016/J.PHRS.2015.06.014
Zhiyun Yu, Gang Zhao, Guifang Xie, Liyan Zhao, Yong Chen, Hongquan Yu, Zhonghua Zhang, Cai Li, Yunqian Li, Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo Oncotarget. ,vol. 6, pp. 32930- 32943 ,(2015) , 10.18632/ONCOTARGET.5405
Ping Wang, Donghong Kang, Wei Cao, Yan Wang, Zhiwen Liu, Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Diabetes-metabolism Research and Reviews. ,vol. 28, pp. 109- 122 ,(2012) , 10.1002/DMRR.1291
Sirwan M. Hadad, Philip Coates, Lee B. Jordan, Ryan J. O. Dowling, Martin C. Chang, Susan J. Done, Colin A. Purdie, Pamela J. Goodwin, Vuk Stambolic, Stacy Moulder-Thompson, Alastair M. Thompson, Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial Breast Cancer Research and Treatment. ,vol. 150, pp. 149- 155 ,(2015) , 10.1007/S10549-015-3307-5
Juan Wang, Gen Sheng Wu, Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells Journal of Biological Chemistry. ,vol. 289, pp. 17163- 17173 ,(2014) , 10.1074/JBC.M114.558288
Noboru Mizushima, Masaaki Komatsu, Autophagy: Renovation of Cells and Tissues Cell. ,vol. 147, pp. 728- 741 ,(2011) , 10.1016/J.CELL.2011.10.026
Swaroopa Yerrabothala, Hamid Shaaban, Gerardo Capo, Michael Maroules, Vincent A. Debari, The Impact of Diabetes Mellitus on Breast Cancer Outcomes: A Single Center Retrospective Study Pathology & Oncology Research. ,vol. 20, pp. 209- 214 ,(2014) , 10.1007/S12253-013-9666-5
Patricia V. Schoenlein, Sudharsan Periyasamy-Thandavan, Julia S. Samaddar, William H. Jackson, John T. Barrett, Autophagy facilitates the progression of ERα-positive breast cancer cells to antiestrogen resistance Autophagy. ,vol. 5, pp. 400- 403 ,(2009) , 10.4161/AUTO.5.3.7784
Douglas Hanahan, Robert A Weinberg, The hallmarks of cancer. Cell. ,vol. 100, pp. 57- 70 ,(2000) , 10.1016/S0092-8674(00)81683-9